Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Pharmaceutical Marketing Company So-net M3 Estimates Double-digit Growth

This article was originally published in PharmAsia News

Executive Summary

Japanese pharmaceutical information provider So-net M3 reported April 23 that the company's net profit increased by 20 percent to ¥2.3 billion ($23.7 million), the company also increased dividends by ¥300 to ¥3000. For fiscal year 2009, M3 estimated another double-digit growth rate of 14 percent in net profit to ¥2.7 billion. So-net M3 has expanded marketing support service for Japanese domestic pharmaceutical companies; the company also is growing overseas businesses, mainly targeting the U.S. market. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts